M&A Lab

HTML PDF


M&A Lab November 13, 2008

Ranbaxy-Daiichi Deal Dissected

Dear All,

With the completion of acquisition of 63.92% equity stake in Ranbaxy Laboratories Limited (“Ranbaxy”), India's largest pharmaceutical company, by Japanese pharma major Daiichi Sankyo Co., Ltd. (“Daiichi”), on November 7, 2008, it would be interesting to analyze the key legal and tax issues that arose from the beginning till the completion of this landmark deal.


For a detailed analysis of the legal and tax issues, Initiates file downloadplease click here for the document.


As you would be aware, we have been providing regular information on latest legal developments. M&A Lab is our latest initiative to provide you in depth and knowledge based analysis of latest M&A deals. We will be happy to have your views / comments on our initiative.


– Ruchi BiyaniVaidhyanadhan Iyer & Nishchal Joshipura 
You can direct your queries or comments to Team M&A

Mission and Vision


Distinctly Different


Webinars

Bilateral Investment Claims against India: The Antrix Devas Saga decoded
October 25, 2016

This event is over. For event material please click here


Seminar

Lifecycle of India Focused Funds
June 08, 2017

This event is over. For event material please click here

Want to work with us?


HIRING Now!!

Inviting Top Talent for our Corporate, Funds and International Tax Practices

Strong credentials in Corporate Law (in particular M&A or Fund Investment), Fund Formation or International Tax? Now’s the time to apply. We’re looking for the industry's best talent with scope to do extraordinary work for the world’s best, marquee clients. Reach out for a great career in a great place!

Write to happiness(at)nishithdesai.com


TO LEARN MORE ABOUT US

CLICK HERE.


Nishith Desai Associates 2013. All rights reserved.